Kyung-Soo Inn, ACA

Dr. Kyung-Soo Inn, who has a massive experience in ubiquitination and antiviral innate immune signaling, serves as Chief Executive Officer at Prazer Therapeutics. Prazer is established on the groundbreaking science from the laboratories of Professor Kyung-Soo Inn, Nam-Jung Kim, and Jong-Kil Lee at Kyung Hee University in South Korea. Dr. Inn is Department Chair of Pharmaceutical Science at the College of Pharmacy, Kyung Hee University. He also worked at Aprogen in South Korea, where he served as head of the Therapeutic Antibody Development Team. Dr. Inn obtained his B.S. degree in Biological Science from Korea Advanced Institute of Science and Technology (KAIST) and obtained his Ph.D. in Microbiology and Immunology from Seoul National University College of Medicine. He also completed his post-doctoral studies at Harvard Medical School and University of Southern California (USC) Keck School of Medicine.